About this trial
We will conduct a randomized trial to compare differences in sexually transmitted infection (STI) treatment adherence between patients receiving text messages versus those receiving usual care (e.g. no text messages). We hypothesize that STI treatment adherence will be 20% higher among patients randomized to receipt of two-way text messaging services.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adolescent patients seen in the Emergency Department who test positive for gonorrhea, chlamydia, or pelvic inflammatory disease and are prescribed outpatient antibiotic treatment.
Disqualifiers
Patients will be excluded if they are unable to understand English, are critically ill, have cognitive impairment or if they do not have access to a cellular telephone with text messaging capabilities.
Trial design
Single group
Treatments tested in this trial
mHealth Intervention
BehavioralAdolescents will receive text messages to facilitate treatment adherence
Treatment groups
Trial outcomes
Primary outcomes
STI treatment adherence
Proportion of study participants who complete their medication as prescribed by self-report
Secondary outcomes
STI treatment receipt
Proportion of study participants who receive STI treatment; measured by prescription filling and/or receiving treatment at a healthcare facility
Sponsors and contacts
Click on the lead sponsor to view all of their trials.